INTRODUCTION
Immunity is often classified into adaptive and innate immunity. T-and B-cell-based adaptive immunity is thought to be specific to higher vertebrates. In contrast, innate immunity, such as phagocytosis or the production of antimicrobial peptides, is observed in a wide variety of animals. Such generality indicates that we can use invertebrate model animals to investigate innate immunity.
A good example is a series of studies on the immune regulatory system by the Toll signalling pathway (reviewed in [1] ). Toll was originally identified as a factor regulating dorso-ventral patterning in Drosophila melanogaster. Later, the Toll signalling pathway was suggested to also regulate the gene expression of antimicrobial peptide genes in D. melanogaster. This report stimulated the search for Toll homologues in mammals. Finally, some of the Toll homologues were revealed to be actual regulators of mammalian innate immunity. This example suggests that invertebrate model animals can be powerful tools for identifying innate immune-related molecules by genetic study.
The nematode, Caenorhabditis elegans, is a model animal widely used in the laboratory. Forward and reverse genetic methods have been established, and the entire genomic sequence is now available for C. elegans [2] . C. elegans is thus one of the best candidates for an invertebrate model to study innate immunity. Recently, the mechanisms of bacterial virulence of Pseudomonas aeruginosa ( [3] [4] [5] [6] and reviewed in [7] ) and Salmonella typhimurium [8, 9] were investigated using the C. elegans pathogenesis model. The morphological change induced by a novel bacterial pathogen, Microbacterium nematophilum, was also investigated using the advantages of genetic analysis in C.
cDNA cloning
Mature transcripts for abf-1 and abf-2 were cloned using reverse transcription (RT)-PCR. The poly(A) + RNA isolated from the mixed-stage C. elegans was reverse-transcribed using random 9-mer primers [RNA LA PCR kit (AMV) version 1.1 ; Takara], and a single-stranded cDNA mixture was obtained. First, the internal regions were amplified using the cDNA mixture as templates, i.e. (abf-11s,abf-11as)i(abf-12s,abf-12as) for abf-1, and (abf-13s,abf-13as)i(abf-14s,abf-14as) for abf-2. Next, the 5h terminal regions were amplified using the SL1 primer, i.e. (SL1,abf-11as)i(SL1,abf-12as) for abf-1, and (SL1,abf13as)i(SL1,abf-14as) for abf-2. Finally, polyadenylation sites were determined by 3h rapid amplification of cDNA ends (RACE) using reverse-transcripts and an oligo dT-M13M4 primer as templates, i.e. (abf-11s,M13M4)i(abf-12s,M13M4) for abf-1, and (abf-13s,M13M4)i(abf-14s,M13M4) for abf-2. A polycistronic precursor RNA was also detected by RT-PCR, i.e. (abf11s,abf-13as)i(abf-12s,abf-14as) for the abf operon.
Determination of 5h ends of transcripts for abf-1 and abf-2
A RT-PCR was carried out using specific SL primers, i.e. (SLX,abf-11as)i(SLX,abf-12as) for abf-1, and (SLY,abf13as)i(SLY,abf-14as) for abf-2, where ' SLX ' is an SL1-20 or SL2-20 primer, and ' SLY ' is one of the SL1-20, SL2-20, SL3, SL4 or SL5 primers. gpd-2 and gpd-3 were used as positive controls for the SL2-accepting genes [16] , i.e. (SL2-20,gpdas1)i(SL2-20,GPD-58). The GPD-58 primer was originally used by Spieth et al. [16] . 5h RACE was performed using the 5h RACE system, version 2.0 (Gibco BRL).
Detection of a transcript for C50F2.4
Poly(A) + RNA isolated from the mixed-stage C. elegans was reverse-transcribed using a random 9-mer primer. A transcript for C50F2.4 was detected by RT-PCR using the reverse-transcripts as templates, i.e. (aup-1s,aup-1as)i(aup-2s,aup-2as).
Preparation of genomic DNA from Ascaris suum
The ovaries and uteri were isolated from the adult female A. suum. These tissues were ground in liquid nitrogen. An aliquot of the tissue powder (7 ml) was suspended in 50 ml of an extraction buffer (0.1 M EDTA, 0.5 % SDS and 10 mM Tris\HCl, pH 8.0) containing 20 µg\ml (final concentration) RNase-A (Nippon Gene, Tokyo, Japan). The suspension was incubated at 37 mC for 1 h, in order to degrade the RNA. Subsequently, protease K (150 µg\ml, final concentration) was added, and the suspension was incubated at 37 mC for 18 h. After two extractions with water saturated phenol\chloroform (1 : 1, v\v ; pH 8.0) and propan-2-ol precipitation, the genomic DNA was dissolved in 1 ml of 1iTE [where 1iTE corresponds to 10 mM Tris\HCl (pH 8.0)\1 mM EDTA] [17] . This DNA solution was dialysed against 1iTE at 37 mC for 2 days. This partially purified DNA solution was turbid, due to contamination by polysaccharides. Further purification was achieved using a Qiagen Blood and Cell Culture DNA kit. After this step, the highly purified DNA solution became clear. A total of 140 µg of genomic DNA was obtained. Although other tissues were also subjected to the same procedure, these trials resulted in a lower yield.
Cloning of the asabf gene
The intron of asabf was identified by PCR using the genomic DNA as a template, i.e. (1a-A1-A8,anti 1a R53-C46). The flanking sequences of the asabf gene were cloned by inverse PCR. The genomic DNA of A. suum (0.5 µg) was digested with NsiI (for the 5h flanking region) or KpnI (for the 3h flanking region). The restriction endonucleases were inactivated by phenol\ chloroform (1 : 1, v\v) extraction. Cyclic DNAs were generated by self-ligation of the fragments and were used as templates for inverse PCR, i.e. (1a-as-A1-7C,new inv-1as) for the 5h flanking region, and (1a-s-86S-92H,anti 1a R53-C46) for the 3h flanking region.
Immunofluorescence staining
A peptide from the C-terminus of ABF-2 (Cys'*-Ala)! ; CANGGGDIPLGA) was synthesized and conjugated to keyhole limpet haemocyanin. Rabbits were injected with the conjugated peptide, followed by multiple boosts. Affinity-purified anti-(ABF-2 peptide) antibodies were prepared. The immunofluorescence staining was carried out using whole-mount-fixed larvae and adults as described by Miller and Shakes [18] . Briefly, we fixed the worms in 1 % (v\v) formaldehyde and then permeabilized them by freeze-thawing. The fixed worms were incubated with the affinity-purified anti-(ABF-2 peptide) antibody. A Texas Red-conjugated secondary antibody (Vector Laboratories, Burlingame, CA, U.S.A.) was used at 5 µg\ml for immunofluorescence staining.
gfp reporter constructs (where GFP corresponds to green fluorescent protein)
The putative promoter region of the abf operon was amplified by high-fidelity-PCR using Pyrobest polymerase (Takara) and cosmid C50F2 as a template, i.e. (abf-s3R,abf-as7R) for abf-1 and (abf-s3R,abf-as4R-BamHI) for abf-2. The PCR products were digested with BamHI. A gfp reporter plasmid, pPD95.77, was digested with HindIII, treated with the Klenow fragment and was subsequently digested with BamHI. The PCR products were finally introduced into pPD95.77 using the smooth end and the BamHI site. The plasmids were highly purified using the Qiagen plasmid Midi kit. Subsequently, RNase-A and protease K treatments were performed. Following ethanol precipitation, the plamids were subjected to microinjection into C. elegans.
Generation of transgenic animals
Hermaphrodites were injected with a mixture of pRF4 (90 µg\ml) and a gfp reporter plasmid (75 µg\ml) in 1iTE [19] . Transgenic animals were identified by a roller phenotype.
Northern-blot analysis
Total RNA or poly(A) + RNA was isolated as described above from the embryos obtained using an alkaline hypochlorite treatment [14] . Poly(A) + RNA (2-4 µg) was electrophoresed on a 1.2 % (w\v) agarose slab gel containing 6.6 % (v\v) formaldehyde and was capillary-transferred on to a Gene Screen Plus membrane (DuPont). Parts of cDNA for abf-1 and abf-2 were amplified by PCR, i.e. (abf-10s,abf-11asx)i(abf-11s,abf11as7) for abf-1 and (BamHI-abf-13s,T7-abf-13as) for abf-2. The PCR product was digested with BamHI and used as a template for the RNA probe for abf-2. A digoxigenin-labelled RNA probe was synthesized using a digoxigenin RNA labelling kit (Boehringer Mannheim GmbH). As a control for the loading calibration, the C. elegans homologue of eif was used [20] . The template of the RNA probe for eif was prepared by RT-PCR, i.e. (HindIII-eif-1s,SP6-eif-1as), and was used after HindIII digestion. Prehybridization, hybridization, detection using alkaline phosphatase and CSPD [3-(4-methoxyspiro-o1,2-dioxetane-3,2h-(5h-chloro)tricyclo[3.3.1.13,7]decanq-4-yl) phenyl phosphate], and autoradiography were performed according to the recommendations of the manufacturer.
Computer-assisted sequence analysis
Blast database searches were performed via the following on-line servers : Washington University (http :\\genome.wustl.edu\ gsc\Blast\client.pl), the National Center of Biotechnology Information (http :\\www.ncbi.nlm.nih.gov\blast\), and the National Institute of Genetics (http :\\www.ddbj.nig.ac.jp\c-elegans\html\CE-BLAST.html). Alignment and phylogenetic analysis were carried out using ClustalW (http :\\ www.ddbj.nig.ac.jp\htmls\E-mail\clustalw-j.html) with compensation by eye-fitting. Secretory signal regions were predicted by SignalP (http :\\www.cbs.dtu.dk\services\SignalP\). The theoretical pI and molecular mass were estimated by ExPASy (http :\\www.expasy.ch\tools\pi-tool.html). Other standard sequence analyses were performed using Genetyx-Mac version 7.3 (Software Development, Tokyo, Japan).
Expression and purification of ABF-2
The open reading frame (ORF) of a cDNA clone encoding ABF-2 was amplified by PCR using primers with engineered restriction sites. The PCR product was inserted into pPIC3 (Invitrogen) using the BamHI\EcoRI site. After amplification using Escherichia coli and linearization, the ABF-2 expression construct was transformed into Pichia pastoris GS115 (his4). A transformed strain was grown in 2 % (v\v) methanol\buffered glycerolcomplex medium [BMGY ; 1 % (w\v) yeast extract\2 % (w\v) peptone\100 mM potassium phosphate (pH 6.0)\1.34 % (w\v) yeast nitrogen base\, 4i10 −& % biotin\1 % (v\v) glycerol] in flasks shaken at 30 mC for 7 days. The culture supernatant was diluted with water to a conductivity of 5 mS\cm and then adjusted to pH 6.0 with NaOH. The recombinant ABF-2 was partially purified using cation-exchange chromatography (SPSepharose FF). Further purification was achieved by cationexchange HPLC (Hi Trap SP) using a linear gradient elution (0-300 mM NaCl). The fractions containing ABF-2 were identified using SDS\PAGE. These fractions were subjected to final purification by reversed-phase HPLC (Finepak SIL 300C18 T7) using a linear gradient elution [20-40 % (v\v) acetonitrile containing 1 % (v\v) trifluoroacetic acid]. The purified recombinant ABF-2 was freeze-dried and stored at 4 mC. 
Micro-organisms

Microbicidal assays
Each microbial strain in exponential phase was suspended in 10 µl of 10 mM Tris\HCl, pH 7.5, containing 3-fold serially increasing concentrations of purified recombinant ABF-2 (i.e. 1, 3, 9, 27 etc. µg\ml ASABF). The attenuance of the microbial suspension was adjusted to 0.02 at 650 nm. After a 2 h incubation, the test suspension (5 µl) was diluted 1000 times. The diluted sample (200 µl) was innoculated on to an optimum medium. The number of colonies was counted, and the 50 % microbicidal concentration was determined.
Tricine/SDS/PAGE and Western-blot analysis
To prepare the C. elegans extracts, worms were suspended in 1i SDS\PAGE loading buffer and heated at 100 mC for 20 min. The extract was centrifuged and the supernatant was subjected to electrophoresis. Tricine\SDS\PAGE was performed using 15 % (w\v) polyacrylamide gels with the PAGEL system (ATTO, Tokyo, Japan). Following electrophoresis, the peptides were stained with a silver staining kit (Wako, Tokyo, Japan) or transferred on to a PVDF membrane (Immun-Blot ; Bio-Rad). The membranes were probed with the anti-(ABF-2) antibody followed by a secondary antibody (goat anti-rabbit IgG conjugated to alkaline phosphatase ; ICN). The protein-antibody complexes were detected by the Aurora Western-blot chemiluminescent detection system (ICN).
RESULTS
ASABF-type antimicrobial peptide genes in C. elegans
ASABF was the first reported ASABF-type antimicrobial peptide isolated from the pseudocoelomic fluid of the intestinal parasitic nematode, A. suum [11, 12] . To identify the ASABF-type antimicrobial peptide genes in C. elegans, nucleotide sequence databases were searched using the amino acid sequence of ASABF. Two genes encoding the peptides similar to ASABF were identified only in C. elegans. No other clear-cut homologues have been found in any other organisms. These C. elegans genes encoding the ASABF homologues were designated as abf (antibacterial factor)-1 and abf-2. Although abf-1 had not been predicted in the C. elegans genome database, abf-2 was described as C50F2.e. To confirm that these genes are actually functional, we attempted to clone their cDNAs by RT-PCR. Two distinct forms of cDNAs with different lengths of 5h-untranslated regions (UTRs) were cloned for both abf-1 and abf-2, as described below. Furthermore, we attempted to generate antibodies against the ABFs to detect the products of these genes. An anti-(ABF-2) antibody was successfully obtained. ABF-2 was detected in the C. elegans extract from the mixed-stage by Western-blot analysis ( Figures 1A and 1B) . The predicted amino acid sequences of ABF-1 and ABF-2 were compared with the experimentally determined sequence of ASABF (Figure 2 ). First, a secretory signal region was predicted at the N-terminus of all members. Secondly, a cysteine array consisting of eight cysteine residues was completely conserved, and the sequences were highly identical in this region. Thirdly, an insect\arthropod defensin consensus motif, which was originally identified in insect\arthropod defensins [21] and also in ASABF [12] , was conserved in ABF-1 and ABF-2. 
In vitro antimicrobial activity of recombinant ABF-2
To confirm antimicrobial activity, recombinant ABF-2 was prepared using the yeast P. pastoris expression system. A total of 100 µg of the recombinant ABF-2 was obtained from 1 litre of culture supernatant. No significant contaminant was detected by SDS\PAGE ( Figure 1C) or N-terminal sequencing (results not shown). The first ten amino acid residues at the N-terminus of the recombinant ABF-2 were identical with the predicted mature ABF-2 (DIDFSTXARM), indicating that the native secretory signal was cleaved as predicted by SignalP (Figure 2 ). We next submitted the recombinant ABF-2 to mass spectral analysis and obtained a molecular mass of 6537.3 Da. This is in good agreement with the mass of 6536.6 Da calculated for the predicted mature ABF-2 containing four intramolecular disulphide bridges without a four-residue peptide (IKRG) at the C-terminus, as observed in ASABF [12] .
The microbicidal activity of recombinant ABF-2 was tested ( Table 1 ). All tested Gram-positive bacteria were sensitive. Some Gram-negative bacteria and yeasts were sensitive although others were resistant. The Gram-positive bacteria tended to be more sensitive than the Gram-negative bacteria and yeasts. This tendency is identical with that of ASABF [12, 13] . 50 % microbicidal concentrations were less than 1 µM for the sensitive organisms, suggesting that ABF-2 is a microbicidal peptide.
Both abf-1 and abf-2 generate long SL-trans-spliced and short SL-less mRNAs
The cDNAs for abf-1 and abf-2 were cloned by RT-PCR ( Figure  3 , top left-hand panel). The structures of the transcripts for abf-1 and abf-2 are summarized in Figure 3 (bottom left-hand panel) . Some of the mature mRNAs of C. elegans are known to be modified at their 5h termini by the addition of a 22 nt leader sequence designated SL [22] . To date, SL1-SL5 have been reported (see the Discussion section). The 5h terminal regions were determined by specific amplification using SL primers and 5h RACE. Both transcripts of abf-1 and abf-2 were amplified by the SL1 primer, but not the SL2-SL5 primers (Figure 3 , top right-hand panel). It is noteworthy that the distance between the SL and the translation initiation site (i.e. the 5h-UTR) was long (191 bp for abf-1, and 104 bp for abf-2 ; see Figure 3 , top lefthand panel). On the other hand, short SL-less transcripts were mainly detected by 5h RACE (the lengths of the 5h-UTRs were 25 bp for abf-1, and 17 bp for abf-2). The abf-2 transcripts in which SL2-SL5 were trans-spliced were not detected by 5h RACE.
abf-1 and abf-2 form an operon
The cDNA sequences were compared with the genomic DNA sequence to determine the gene organization (Figure 3 , top lefthand panel and bottom right-hand panel). Both abf-1 and abf-2 were found in the cosmid C50F2 from chromosome I. abf-1 and abf-2 were aligned in the same direction and formed a gene cluster. Although abf-2 was an intron-less gene, abf-1 was interrupted by a single intron.
In C. elegans, a number of genes are arranged in operons, transcribed as polycistronic precursor RNAs [22] . The polycistronic precursor RNAs are processed to generate monocistronic mature RNAs. An operon is a cluster of closely spaced genes whose intercistronic space is 0-400 nt [23] . Because the distance between the polyadenylation site of abf-1 and the SL1 acceptor site of abf-2 was only 78 bp, abf-1 and abf-2 were predicted to form an operon [16] . A polycistronic precursor RNA encoding both the ORFs of abf-1 and abf-2 despite loss of the abf-1 intron was detected by RT-PCR, suggesting that abf-1 and abf-2 actually form an operon and are at least partially transcribed as a polycistronic precursor (Figure 3 , bottom lefthand panel). The abf operon was sufficiently compact to be involved in a 1.8 kb intron of the reverse-directed gene C50F2.2 ( Figure 3 , bottom right-hand panel).
Both abf-1 and asabf have a single intron at a conserved position
To estimate the evolutionary relationship, the exon-intron junction of asabf was determined and compared with that of abf-1. The ORF region of asabf was cloned by PCR. The genomic sequence obtained was compared with that of cDNA, and the position of the exon-intron junction was determined. asabf was interrupted by a single intron at the same position as that of abf-1
Figure 5 Expression of abf genes
Left-hand panels : expression of abf-gfp fusion genes in transgenic animals. ABF-1-GFP (construct 1 in Figure 3 , bottom right-hand panel) was observed in the pharyngeal lumen. ABF-2-GFP (construct 2 in Figure 3 , bottom right-hand panel) was mainly detected in the pharyngeal tissue. Right-hand panel : Northern-blot analysis. Total RNA (20 µg) was loaded. As a control for loading calibration, the C. elegans homologue of eif was used. The abf-1 transcripts were detected as five bands. The short SL-less and long SL-trans-spliced transcripts of abf-1 could be the 0.3 and 0.5 kb bands. In contrast, the abf-2 transcript was detected as a single band (0.4 kb, identical with the short SL-less form). The accumulation of both abf-1 and abf-2 transcripts was almost identical in adults of N2 and glp-4(bn2 ), and the eggs.
( Figure 3 , bottom right-hand panel). Furthermore, asabf was analysed by inverse-PCR to determine the entire gene structure, including the 5h-and 3h-UTR regions. No intron was found in asabf other than the intron identically positioned with that of abf-1. Thus the exon-intron organization of asabf is identical with that of abf-1. These results suggest that both the asabf and abf genes have evolved from a common ancestor.
Expression analysis of abf genes
To explore the tissue-specific distribution of abf gene products, an immunofluorescence study was performed using the anti-(ABF-2) antibody. Only the pharyngeal marginal zone was stained in all larval and adult stages, but not in pre-hatching embryos (Figure 4) .
The expression of abf-2 was also examined using gfp reporter constructs. The closest upstream gene of the abf operon was predicted to be the putative gene C50F2.4 (Figure 3 , bottom right-hand panel). The transcript of C50F2.4 was detected by RT-PCR, suggesting that C50F2.4 is a functional gene (results not shown). Based on this result, the gfp reporter plasmid, containing the 2 kb region between the farthest downstream exon of C50F2.4 and abf-1 was used to monitor the expression of abf-2 ( Figure 3 , bottom right-hand panel ; construct 1). ABF-2-GFP was detected in the pharynx in all larval and adult stages, but not in pre-hatching embryos ( Figure 5 , left-hand panels). This result was in accordance with that obtained by the immunofluorescence study. ABF-2-GFP was also observed in the pharyngeal neurons and excretory cells. The expression of abf-1 was also explored by gfp reporter study (Figure 3 , bottom righthand panel ; construct 2). ABF-1-GFP was detected in the pharynx and a part of the body wall muscle in all larval and adult stages, but not in pre-hatching embryos ( Figure 5 , left-hand panels).
Because the gfp transgene experiment is not effective to test the gene expression in germ line cells [24] , Northern-blot analyses were carried out in adults of N2, temperature-induced adult glp-4(bn2) with few eggs, and eggs of N2 ( Figure 5 , right-hand panel). We detected abf-2 transcripts in the adults of N2 and glp-4, and eggs. No obvious difference in the accumulation of abf-2 transcripts was observed. The abf-2 transcript was detected as a single band of 0.4 kb, which was thought to be the short SL-less abf-2 mRNA. The accumulation of abf-1 transcripts was also observed in the adults of N2 and glp-4, and the eggs. The abf-1 transcripts were detected as at least five bands (0.3, 0.5, 1, 2 and 4.5 kb). Although the short SL-less and long SL-trans-spliced transcripts of abf-1 could be the 0.3 and 0.5 kb bands respectively, the 1, 2 and 4.5 kb bands were unexpected. No genes whose sequence was significantly similar to abf-1 or abf-2 have been detected in the C. elegans genome database.
DISCUSSION
ASABF-type antimicrobial peptides in C. elegans
In the present study, we have reported the presence of ASABFtype antimicrobial peptide-like genes in C. elegans, abf-1 and abf-2. The antimicrobial activity of the recombinant ABF-2 against various microbes was confirmed in itro. C. elegans should at least possess an immune defence system against microbes, due to these antimicrobial peptides. This is believed to be the first report of immune effector molecules in C. elegans. In addition, the gene organization and expression of the ASABF-type antimicrobial peptide family is described. In our previous study, an expressed sequence tag-predicted peptide, yk150c7, and a gene predicted by the genomic sequence, T22H6.5, were described as ASABF homologues in C. elegans [12] . yk150c7 and T22H6.5 are still thought to be ASABF-related, because of the significant similarity in their predicted amino acid sequence and gene organization (H. Zhang and Y. Kato, unpublished work). However, abf-1 and abf-2 should be genes more closedly related to ASABF because the sequence identity of these peptides to ASABF is much higher than that of yk150c7 and T22H6.5. yk150c7 and T22H6.5.
Advantage of combinational analysis with A. suum
In many invertebrates, antimicrobial peptides are produced for defence against the infection of microbes [25] . As the first step to reveal the immune defence system of C. elegans, we decided to identify the immune effector molecules that contribute to the defence against microbes, such as antimicrobial peptides, as previously described [11, 12] . However, database searches could not find any clear-cut homologues for known antimicrobial peptides isolated from other animals, and this situation has not changed. The length of the antimicrobial peptides is not very considerable, e.g. cecropins and defensins are approx. 30-40 residues long [25] . In addition, the molecular evolution of antimicrobial peptides tends to be rapid, presumably due to coevolution with invading microbes [25] . An extreme example is the mature region of mammalian defensin whose amino acid changes have occurred in a co-ordinated fashion, i.e. changed molecules were positively selected [26] . Thus the database searches using sequences from evolutionally distant animals should not be effective in identifying the immune-related peptides susceptible to variation, such as antimicrobial peptides, even though the C. elegans genome sequence project has already been completed. Next, we intended to directly purify antimicrobial peptides from C. elegans. However, C. elegans is a very small animal (approx. 1 mm in length). The whole bodies of C. elegans contain a wide variety of proteins\peptides from all tissues, and are not suitable for the purification of tissue-specific peptides. In contrast, the parasitic nematode A. suum is big enough (adult females are 25-35 cm in length) for isolation of the pseudocoelomic fluid. The pseudocoelomic fluid was much less complex. Actually, antimicrobial activity was detected in the pseudocoelomic fluid, in addition to bacteriolytic and agglutinating activities [11] . Finally, we decided to purify the antimicrobial peptides in the body fluid of A. suum and subsequently search the C. elegans genome sequence database to identify their homologues. Consequently, ASABF was purified from the pseudocoelomic fluid of A. suum, and its primary structure was determined [12] . Currently, ABF-1 and ABF-2 are the only clear-cut homologues of ASABF, detected by database searches using the Blast algorithm. No homologues have been found in other evolutionally distant organisms. In addition, we could not find any C. elegans homologues of antimicrobial peptides isolated from higher animals, such as insects or vertebrates. This observation is consistent with the tendency of rapid molecular evolution of antimicrobial peptides [25] , i.e. even if antimicrobial peptides in nematodes were evolutionally related to those in higher animals, it is difficult to detect their counterparts using sequence similarity. The recombinant ABF-2 was a potent antimicrobial peptide and is thought to be functionally identical to ASABF. In addition, the same origin of abf-1 and asabf was suggested by the study of the exon-intron junction, suggesting that A. suum is proximal enough in evolution to C. elegans to predict true homologues of immune-related factors liable to vary, such as antimicrobial peptides. Furthermore, A. suum is big enough for purification and chacterization of tissue-specific proteins\peptides. These results suggest that the combination of biochemical identification in A. suum and homologue hunting in C. elegans is a powerful method of finding rapidly evolved proteins, such as some immune-related molecules in C. elegans.
Physiological role of abf genes
Immunofluorescence and transgenic studies revealed that ABF-2 is mainly produced in the pharynx and may be secreted into the lumen. This observation is consistent with the prediction that ABF-2 is a secretory peptide. It is noteworthy that live bacteria are concentrated in the pharynx due to normal feeding, because C. elegans is a natural bacteria eater. Thus ABF-2 should defend the pharyngeal tissue against microbial infection from the lumen. The recombinant ABF-2 was a potent antimicrobial peptide effective against Gram-positive and Gram-negative bacteria, and yeasts, suggesting that ABF-2 should contribute to the defence against a wide variety of microbes. The surface defence in the digestive tract, respiratory apparatus, epidermis, or reproductive organs by antimicrobial peptides has also been observed in insects and vertebrates, suggesting that this defence strategy is of evolutionally ancient origin. Another possible role of ABF-2 is to help with the digestion of ingested bacteria. The possibility that these antimicrobial peptides also contribute to defence in other tissues, in which GFP fusion peptides were detected, is not yet excluded.
Both ABF-1 and ABF-2 were undetectable in pre-hatching embryos by immunofluorescence and transgenic studies. Worms could be exposed to more severe bacterial stress after hatching because of the loss of egg shells as a physical barrier and the start of ingestion. Thus the post-hatching production of these antimicrobial peptides is thought to be well adapted. However, the transcripts of abf-1 and abf-2 were also detected in eggs by Northern-blot analysis, suggesting some possibilities of contribution to the defence in eggs and\or embryos.
Model for abf gene regulation : a hypothesis
abf-1 and abf-2 are located side-by-side, in the same direction. The gene organization predicted that these genes form an operon. A polycistronic precursor RNA encoding both ORFs of abf-1 and abf-2 was detected by RT-PCR, suggesting that abf-1 and Figure 6 Model for gene regulation of abf genes abf-2 actually form an operon. Therefore abf-1 and abf-2 are at least partially synchronously transcribed as an operon.
However, some atypical properties were found in the abf operon. First, the downstream gene, abf-2, received only SL1, but not SL2 or SL3-SL5. The addition of SL1 and SL2 is thought to be regulated in different manners depending on gene organization [22] . Usually the most upstream genes in the operons or non-operon genes exclusively receive SL1. In contrast, the downstream genes in the operons are known to be trans-spliced to SL2 or ' novel ' SLs, i.e. SL3, SL4 or SL5. In some cases, the downstream genes also receive a mixture of SL1 and SL2. Only the downstream genes with no intercistronic regions are exclusively trans-spliced to SL1 [23] . abf-2 was exclusively transspliced to SL1, and there was an intercistronic region of 78 bp (Figure 3, top left-hand panel) .
Secondly, short SL-less transcripts for both abf-1 and abf-2 were detected. The trans-splicing of SL is thought to be essential for the processing of polycistronic precursor RNAs. These short SL-less mRNAs are not predicted to be the transcripts generated from the operon. No similarity was detected near the 5h terminal region of these short SL-less transcripts, suggesting that these transcripts are not generated by a common machinery. In addition, TATA-box-like (k29 for abf-1, and k25 for abf-2) and CCAAT (k67 for abf-1) sequences were found in the upstream region of the short SL-less transcripts, suggesting that these could be produced as the transcripts of single genes ( Figure  3 , top left-hand panel). We, thus, speculate that abf-1 and abf-2 could be expressed in two separate ways, i.e. (1) synchronous expression as an operon, and (2) independent expression as multiple single genes ( Figure 6 ). This hypothesis does not conflict with the observation that the tissue distributions of ABF-1-GFP and ABF-2-GFP were not completely identical, although both GFP fusion proteins were detected in the pharynx, i.e. abf-1 and abf-2 could not always be synchronously expressed, and the accumulation of these transcripts might be independently regulated. Further study is needed to reveal the exact mechanism of the gene regulation and RNA processing for the abf genes, also including the unexpectedly large transcripts of abf-1. However, it is at least suggested that some operons predicted by genomic sequences can be independent genes. Twenty-five percent of genes in C. elegans were predicted to form operons [27] . This ' opportunistic ' operon hypothesis should be examined in other predicted operons.
